Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
S-3/APre-effective amendment to an S-3 filingDec 26, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 17, 2001View HTMLDownload DOCDownload PDFDownload XLS
424B1Form of prospectus that discloses information previously omitted from the prospectusDec 7, 2001View HTMLDownload DOCDownload PDFDownload XLS
S-3MEFRegistration of up to an additional 20% of securities for any offering registered on a S-3Dec 7, 2001View HTMLDownload DOCDownload PDFDownload XLS
S-3/APre-effective amendment to an S-3 filingDec 4, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-K/AAmendment to a previously filed 8-KNov 15, 2001View HTMLDownload DOCDownload PDFDownload XLS
S-3Simplified registration formNov 9, 2001View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionNov 9, 2001View HTMLDownload DOCDownload PDFDownload XLS
S-3Simplified registration formNov 6, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 2, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 2, 2001View HTMLDownload DOCDownload PDFDownload XLS
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisOct 31, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 26, 2001View HTMLDownload DOCDownload PDFDownload XLS
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisOct 16, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 10, 2001View HTMLDownload DOCDownload PDFDownload XLS
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisOct 2, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventSep 11, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventSep 6, 2001View HTMLDownload DOCDownload PDFDownload XLS
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisAug 23, 2001View HTMLDownload DOCDownload PDFDownload XLS
POS AMPost-effective amendment to an S-Type filingAug 16, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventAug 16, 2001View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionAug 14, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 25, 2001View HTMLDownload DOCDownload PDFDownload XLS
S-3/APre-effective amendment to an S-3 filingJun 19, 2001View HTMLDownload DOCDownload PDFDownload XLS
S-3Simplified registration formMay 21, 2001View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-35

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information